EXPLORER RCT proves the sooner UrgoStart treatment is initiated, the better the outcome.
•71% of wounds completely healed after 20 weeks of treatment
•Reduced healing time by 60 days on average
The UrgoStart treatment range gives you better outcomes AND saves on treatment costs.
You generate significant savings per patient due to reduced healing time, reduced dressing changes and nursing time & reduced complications.
ACCOLADES
An Innovation with a
High Level of Recognition
Recognition by the HAS
(French Health Care Authorities), France
August, 2018
PUBLICATION
of Explorer
in the Lancet Diabetes & Endocrinology
March, 2018
"Innovation Team Best Practices" AWARD, La Sorbonne, France
September, 2018
The NICE GUIDANCE:
“TLC-NOSF to Treat DFU & VLUS”, UK
January, 2019
The "Prix Galien" AWARD, France
December, 2018
International Working Group on Diabetic Foot Guidelines***
May, 2019
The “Most Innovative Product” JWC AWARD
March, 2019
"Innovative
Health Solution" PRIZE, Spain
July, 2018
KEEP CONNECTED
At UrgoStart Plus we continue to evaluate our ideas,
enhance our skills and gain access to the most
cutting-edge technologies.
Sign up for a quarterly NEWSLETTER.
Learn about our latest products and technologies.
Request a starter pack.
SPEAK WITH
your account manager
1. Münter KC, Meaume S, Augustin M, Senet P, Kérihuel J.C. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC NOSF wound dressings. J Wound Care. 2017 Feb; 26 ( S4 S15. Erratum in: J Wound Care. 2017 Mar 2; 26(3): 153.
2. Edmonds M, Lázaro Martínez JL, Alfayate García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186 196.*. |
3. Sigal ML, Addala A, Maillard H, Chahim M, Sala F, Blaise S, Dalac S, Meaume S, Bohbot S, Tumba C, Tacca O. Clinical evaluation of a new TLC NOSF dressing with poly absorbent fibers for the local management of exuding leg ulcers, at the different stages of the healing process: Results from two multicentric, single arm, prospective, open label clinical trials. J Wound Care 2019: 28(3) 3):164 175
URGO Medical North America, 3801 HulenSt. Ste 251, Fort Worth,
TX 76107
1-888-446-4143
Copyright © 2020 UrgoStart Plus. All Rights Reserved. Website by willowgraphix.com